Petroleo Brasileiro SA Petrobras
PBR
Ecopetrol
EC
D.R. Horton
DHI
Vale SA
VALE
Lennar Corp
LEN
US Stock MarketDetailed Quotes
PCRX Pacira BioSciences
- 19.565
- -0.245-1.24%
Trading Dec 27 12:46 ET
903.38MMarket Cap-9.88P/E (TTM)
20.040High19.470Low147.66KVolume19.820Open19.810Pre Close2.91MTurnover0.32%Turnover Ratio21.98P/E (Static)46.17MShares35.95052wk High1.21P/B893.62MFloat Cap11.16452wk Low--Dividend TTM45.67MShs Float121.950Historical High--Div YieldTTM2.88%Amplitude6.160Historical Low19.674Avg Price1Lot Size
Pacira BioSciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 21.34%53.92M | 22.38%53.24M | 156.70%49.1M | 6.45%154.65M | 13.20%47.58M | 4.18%44.44M | 45.94%43.5M | -37.85%19.13M | 15.56%145.27M | 81.08%42.04M |
| Net income from continuing operations | -1,421.29%-143.47M | -26.69%18.89M | 145.96%8.98M | 163.72%41.96M | 346.19%24.87M | 1,666.81%10.86M | 29.62%25.76M | -386.12%-19.54M | -62.10%15.91M | -96.92%-10.1M |
| Operating gains losses | --0 | ---- | ---- | --16.93M | --0 | --0 | --0 | 62,588.89%16.93M | ---- | ---- |
| Depreciation and amortization | 9.87%20.25M | -1.00%18.86M | -6.00%18.43M | -17.41%75.57M | -39.21%18.49M | -8.74%18.43M | -8.68%19.05M | -2.15%19.6M | 220.52%91.5M | 132.64%30.41M |
| Deferred tax | -77.31%1.12M | 9.55%12.54M | 147.17%3.46M | 296.54%15.62M | 160.89%6.6M | 600.00%4.91M | 428.74%11.44M | -25,417.24%-7.34M | -173.08%-7.95M | -420.90%-10.84M |
| Other non cash items | -143.07%-2.54M | 113.32%2.33M | -122.93%-3.03M | 111.19%2.46M | 121.19%854K | 532.90%5.91M | 11.14%-17.51M | 1,522.48%13.21M | -205.97%-21.98M | -143.19%-4.03M |
| Change In working capital | 125.46%2.09M | 29.39%-4.39M | 151.59%8.11M | -178.57%-45.78M | -608.93%-15.65M | -846.02%-8.2M | -19.06%-6.21M | -93.04%-15.72M | 12.00%-16.43M | -835.17%-2.21M |
| -Change in receivables | 94.39%4.13M | 46.54%-3.14M | -24.56%3.92M | -244.35%-7.16M | -74.56%-8.6M | 189.73%2.12M | -688.68%-5.88M | 23.18%5.19M | 80.07%-2.08M | 63.52%-4.93M |
| -Change in inventory | -91.96%-8.43M | -885.95%-6.66M | 145.37%7.57M | -433.47%-8.29M | -1,165.71%-7.83M | -215.86%-4.39M | -72.45%847K | 160.37%3.09M | 155.65%2.49M | 138.54%735K |
| -Change in prepaid assets | -92.17%-5.03M | 9.70%-2.21M | 146.57%897K | -257.13%-9.64M | -24.50%-2.65M | -198.20%-2.62M | -337.88%-2.44M | 54.79%-1.93M | -336.34%-2.7M | -1,006.81%-2.13M |
| -Change in payables and accrued expense | 483.83%11.82M | 444.02%7.64M | 84.42%-3.51M | -55.49%-21.12M | -42.48%3.05M | 39.60%-3.08M | 113.09%1.4M | -635.99%-22.49M | -182.37%-13.59M | -59.43%5.29M |
| -Change in other current liabilities | -70.17%-405K | 86.71%-19K | -283.14%-771K | 178.06%434K | 133.42%394K | -265.28%-238K | -134.96%-143K | 501.43%421K | -434.62%-556K | -162.32%-1.18M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 21.34%53.92M | 22.38%53.24M | 156.70%49.1M | 6.45%154.65M | 13.20%47.58M | 4.18%44.44M | 45.94%43.5M | -37.85%19.13M | 15.56%145.27M | 81.08%42.04M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1,101.36%-52.16M | -307.68%-15.22M | -123.47%-15.53M | 134.43%77.54M | -25.16%8.37M | 90.86%-4.34M | -61.77%7.33M | 131.82%66.18M | -983.14%-225.19M | -83.28%11.19M |
| Net PPE purchase and sale | -20.57%-4.09M | 53.29%-1.59M | 56.80%-2.84M | 49.59%-15.16M | 67.26%-1.8M | 34.49%-3.39M | 70.99%-3.4M | 14.38%-6.57M | 34.43%-30.08M | 40.08%-5.49M |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Net investment purchase and sale | -4,970.78%-48.07M | -226.98%-13.63M | -117.45%-12.69M | 156.83%92.7M | -39.02%10.17M | 97.76%-948K | -65.27%10.73M | 143.21%72.75M | -136.32%-163.11M | -96.66%16.68M |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -700.00%-32M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1,101.36%-52.16M | -307.68%-15.22M | -123.47%-15.53M | 134.43%77.54M | -25.16%8.37M | 90.86%-4.34M | -61.77%7.33M | 131.82%66.18M | -983.14%-225.19M | -83.28%11.19M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 89.76%-2.85M | 5,577.27%24.98M | 98.17%-2.82M | 54.42%-183.03M | 96.96%-1.78M | -257.39%-27.79M | 100.29%440K | 15.24%-153.91M | -205.47%-401.53M | -116.19%-58.51M |
| Net issuance payments of debt | 89.89%-2.81M | 3,123.57%85.05M | 98.09%-2.81M | 57.74%-180.76M | 95.26%-2.81M | -196.66%-27.81M | 98.31%-2.81M | 23.51%-147.33M | -217.58%-427.69M | -116.32%-59.38M |
| Net common stock issuance | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | -106,936.00%-26.71M | -58.07%1.36M | --0 | -82.63%4.75M | -44.14%1.14M | -98.44%25K | -74.34%3.25M | -96.98%333K | 2.57%27.34M | -66.20%2.04M |
| Net other financing activities | --26.68M | ---36.44M | 99.94%-4K | -497.36%-7.02M | ---106K | --0 | --0 | ---6.91M | 87.90%-1.18M | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 89.76%-2.85M | 5,577.27%24.98M | 98.17%-2.82M | 54.42%-183.03M | 96.96%-1.78M | -257.39%-27.79M | 100.29%440K | 15.24%-153.91M | -205.47%-401.53M | -116.19%-58.51M |
| Net cash flow | ||||||||||
| Beginning cash position | 184.59%247.05M | 417.80%184.05M | 47.21%153.3M | -82.22%104.14M | -9.42%99.12M | -28.88%86.81M | -84.32%35.55M | -82.22%104.14M | 485.83%585.58M | -18.36%109.42M |
| Current changes in cash | -108.84%-1.09M | 22.89%63M | 144.83%30.75M | 110.21%49.16M | 1,125.15%54.18M | 197.40%12.31M | 148.97%51.27M | 80.88%-68.59M | -199.14%-481.44M | -101.17%-5.29M |
| End cash Position | 148.15%245.97M | 184.59%247.05M | 417.80%184.05M | 47.21%153.3M | 47.21%153.3M | -9.42%99.12M | -28.88%86.81M | -84.32%35.55M | -82.22%104.14M | -82.22%104.14M |
| Free cash flow | 21.40%49.83M | 28.81%51.65M | 268.26%46.27M | 21.09%139.49M | 25.29%45.79M | 9.53%41.04M | 121.87%40.1M | -45.64%12.56M | 44.27%115.2M | 160.13%36.55M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.